Investor-Ready Websites & Digital Platforms for Boston Biotech Founders

Designing and building investor-ready biotech websites aligned with your pitch deck and fundraising narrative.

C&C Helps Founders With:

Cutting-edge fundraising websites
Pitch-deck aligned digital narratives
AI-ready discoverability
Secure investor portals

WHO THIS IS FOR

Built for Biotech Founders Preparing to Raise

Charles & Codon partners with science-driven teams who need to translate real breakthroughs into investor-ready narratives — without oversimplifying or overhyping.

Pre-Seed to Series A Founders

You’re preparing for a pre-seed, seed, or Series A raise and need your website to clearly support your investment thesis.

Science-Led Teams

Your technology is complex, differentiated, and defensible. You need help translating deep science into a narrative investors can quickly understand and believe.

Companies Signaling Credibility

You need to look credible to venture investors, strategic partners, and senior hires, nd your digital presence needs to reflect the maturity of your company today, not last year.

Not a fit for consumer startups, experimental side projects, or teams looking for a quick marketing site.

WHY INVESTORS CARE

Your Website is Part of the Raise

Investors use your site to validate your story fast. If your narrative is unclear, inconsistent with the deck, or feels early, it creates friction that slows momentum.

Founder Strategy Call

Narrative Clarity

Investors need to understand your thesis in 60 seconds. We structure your story so the “what / why / why now” lands immediately.

Deck-to-Site Consistency

Mismatches between the pitch deck and website raise flags. We align messaging, claims, and proof points across both.

Diligence-Ready Signals

Your digital presence should communicate operational maturity — team credibility, scientific rigor, and clear milestones — without hype.

HOW IT WORKS

A Focused Process Built for Fundraising Timelines

We work fast, stay opinionated, and focus only on what moves your raise forward.

01

Narrative Synthesis

The Audit. A 360° forensic analysis of the pitch deck and scientific thesis. This identifies credibility gaps and refines the value proposition to match current market rationalization. The result is a unified narrative that translates complex biology into an institutional-grade investment thesis.

02

Intelligent Architecture

The Core Build. A high-performance digital platform engineered for speed and precision. The website is optimized for both human diligence (SEO) and Generative Engine Optimization (GEO). It ensures your science is correctly indexed and prioritized by AI tools used by Tier-1 analysts.

03

Diligence Hardening

The Security Layer. Transforming the platform into a diligence-ready asset. This phase integrates secure investor portals and SOC 2 compliant foundations. The content architecture is designed to withstand the scrutiny of multi-stage technical and regulatory audits.

04

Continuous Synthesis

The Evolution. Ongoing strategic oversight to manage clinical milestones and data readouts. Your digital presence evolves at the same pace as your science. We ensure the narrative remains sharp and effective through the next funding inflection point.

START HERE

Start with a Founder Strategy Call

A focused 30-minute working session to assess your narrative, website, and fundraising readiness — and determine whether it makes sense to work together.

Strategy Call

Built for pre-seed to Series A biotech founders preparing to raise.

THE LONGFELLOW LETTER

Founder Insights From Kendall Square

Short, practical notes on biotech fundraising narratives, investor credibility, and what founders need to signal before a raise.